- Telehealth visits
Fernando Gonzalez, MD
Neonatology- Telehealth visits
Fernando Gonzalez, MD
Neonatology- Telehealth visits
On this page
About me
Dr. Fernando Gonzalez is a neonatologist who specializes in caring for newborns with brain injuries and infants requiring extracorporeal membrane oxygenation (oxygen support from an artificial lung), including premature infants.
Gonzalez's research focuses on brain injury in newborns, stroke in newborns, hypoxic-ischemic encephalopathy (brain damage from insufficient blood flow or oxygen), neurogenesis (the process by which the brain's nerves cells form) and stem cell plasticity (the ability of stem cells to switch to a different type).
Gonzalez earned his medical degree at the Warren Alpert Medical School of Brown University. He completed a residency in pediatrics at Harbor – UCLA Medical Center and a fellowship in neonatology at UCSF.
Education & training
Board certification
- Neonatal-Perinatal Medicine, American Board of Pediatrics
Fellowship
- Neonatal-Perinatal Medicine, UCSF School of Medicine -GME
Residency
- Pediatrics, Harbor / UCLA Medical Center
Internship
- Pediatrics, Harbor / UCLA Medical Center
Degree
- MD, Warren Alpert Medical School of Brown University
Academic Title
- Professor
My expertise
Specialties
My research
Clinical trials
Cool Prime Comparative Effectiveness Study for Mild HIEOpens in a new window
Recruiting
Effectiveness of normothermia in infants is measured by Composite Bayley IV score scale, which is. an extensive formal developmental assessment tool for diagno...
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.